Friday, July 16, 2021

Saturday, July 17, 2021

Friday, July 16, 2021

7:45 – 8:30 AM

Evolving the Chronic Heart Failure Treatment Paradigm in Cardiology
Jane E. Wilcox, MD, MSc
Novartis Industry Supported Lecture – Not eligible for CME Credit

8:30 – 8:35 AM

Break & Virtual Exhibits

Session I: Current Approaches to the Management of Heart Failure
Moderator: Kirkwood F. Adams, Jr., MD

8:35 – 8:40 AM

Introduction & Program Overview

Kirkwood F. Adams, Jr., MD

8:40 – 9:00 AM

Clinical Challenges: Therapeutic Concepts in Heart Failure with Preserved EF

Marvin A. Konstam, MD

9:00 – 9:20 AM

CHF With Preserved EF – Classical Trial Data

Peter E. Carson, MD

9:20 – 9:40 AM

HFpEF: Emerging Trial Data Leading Us in Novel Directions

Kavita Sharma, MD

9:40 – 9:55 AM

Break & Virtual Exhibits

9:55 – 10:15 AM

“Old School” But Still Essential Drug Therapies for Heart Failure

Stephanie H. Dunlap, DO

10:15 – 11:00 AM

Optimizing Polypharmacy – Strategies to Resolve Treatment Gaps

Gaps: Moderators: Kirkwood F. Adams, Jr, MD
Speaker: Nancy M. Albert, PhD, RN
Panelists: NH Antagonists: Javed Butler, MD, MPH, MBA Aldo Blockade: Marvin Konstam, MD Hydralazine–Nitrate: Alan B. Miller, MD Diuretics: G. Michael Felker, MD, MHS

11:00 – 11:40 AM

Making Polypharmacy Work in the Clinic – Case Vignettes with Discussion

Case Presenters: Douglas D. Schocken, MD and Sara Paul, DNP
Case Discussants: Stephanie H. Dunlap, DO, Robert L. Page II, PharmD, and Hector O. Ventura, MD

11:40 – 12:30 PM

Expert Panel Discussion: Bench to Bedside in HFpEF: Evaluating Mechanistic and Clinical Evidence

Moderator: Kirkwood F. Adams, Jr., MD 
Speakers: Robert J. Mentz, MD  
Panelists: Peter P. Liu, MD
, David E. Lanfear, MD, MS, Christopher M. O’Connor, MD and Mona Fiuzat, PharmD

12:30 – 1:45 PM

Lunch Break & Virtual Exhibits

Session II: Electrophysiological Approaches to Heart Failure
Moderator: Alan B. Miller, MD

1:45 – 2:05 PM

Cardiac Contractility Modulation Therapy for Heart Failure

Faisal F. Syed, BSc, MBChB

2:05 – 2:25 PM

Electrophysiologist’s Perspective: How Can Implantable Cardiac Rhythm Management Devices Help My Heart Failure Patients?  

Anil K. Gehi, MD

2:25 – 2:45 PM

Heart Failure Specialist Perspective: EP Devices – Who, When and What?

Alan B. Miller, MD
Panelists: Anil K. Gehi, MD, and Faisal F. Syed, BSc, MBChB

2:45 – 3:00 PM

Break & Virtual Exhibits

Session III: Surgical Strategies for Heart Failure
Moderator: Patricia P. Chang, MD, MHS

3:00 – 3:20 PM

Ventricular Assist Devices: Latest Strategies for Optimal Clinical Application

Mirnela Byku, MD, PhD

3:20 – 3:40 PM

Mitral Regurgitation: Causes, Natural History, Classic and Novel Interventions

JoAnn Lindenfeld, MD

3:40 – 4:00 PM

Real World Insights on Cardiac Assist Devices and Transplantation

James B. Young, MD

4:00 – 4:35 PM

Surgical Approaches to Advanced Heart Failure: Patient Selection and Timing

Case Presenter: Sudha Jaganathan, MD Case Discussant: Patricia P. Chang, MD, MHS
Panelists: James C. Fang, MD, James B. Young, MD, Mirnela Byku, MD, PhD, Christopher V. Chien, MD, and JoAnn Lindenfeld, MD

4:35 – 5:15 PM

Featured Panel Discussion:  Device Options for Fluid Management: Focus on Clinical Application

Moderator: Kirkwood F. Adams, Jr., MD 
Speakers: JoAnn Lindenfeld, MD and Christopher V. Chien, MD
Commentary: Patricia P. Chang, MD, MHS and James C. Fang, MD

Saturday, July 17, 2021

Session IV: Future Directions in Heart Failure Therapy:  Drug Innovation and Late Breaking Trials
Moderator: Kirkwood F. Adams, Jr., MD

8:35 – 8:40 AM

Update on HFSA 2021

John D. Barnes

8:40 – 9:00 AM

Advances in Diagnosis and Treatment of Cardiac Amyloid: Key Role Novel Drug Therapy

Mathew S. Maurer, MD

9:00 – 9:10 AM

Sudden Death in Cardiac Amyloid

Alan B. Miller, MD

9:10 – 9:25 AM

Clinical Discussion of Nuances in the Management of Cardiac Amyloid

Mathew S. Maurer, MD and Alan B. Miller, MD

9:25 – 9:35 AM

Myosin Modulation: Mavacamten in Obstructive Hypertrophic Cardiomyopathy

Kirkwood F. Adams, Jr., MD

9:35 – 9:55 AM

Guanylate Cyclase Stimulation–Vericiguat: Insights VICTORIA and VITALITY–HFpEF Trials

Robert J. Mentz, MD

9:55 – 10:10 AM

Myosin Modulation: Update on Omecamtive Mecarbil in HFrEF: Latest Galactic-HF Results

Kirkwood F. Adams, Jr., MD

10:10 – 10:20 AM

Break & Virtual Exhibits

10:20 – 10:40 AM

CHF and Diabetes Treatment Intersection – SGLT2 Inhibitors to Improve CV Outcomes

Javed Butler, MD, MPH, MBA

10:40 – 11:00 AM

Update on Novel Therapeutic Approaches to Heart Failure

Barry Greenberg, MD

11:00 – 11:45 AM

Featured Panel
Expert Panel Discussion:  Potential Opportunities and Challenges for Novel Therapies as Components of the Polypharmacy of Heart Failure: Latest Clinical Perspectives

Moderator: Kirkwood F. Adams, Jr., MD
Speakers: Clyde W. Yancy, MD, MSc
Panelists: Ileana L. Piña, MD, MPH, David E. Lanfear, MD, MS, Barry Greenberg, MD, Robert J. Mentz, MD, and Javed Butler, MD, MPH

11:45 – 12:45 PM

Lunch Break & Virtual Exhibits

Session V: Clinical Science to Clinical Care – Making it Happen in the CHF Clinic
Moderator: Kirkwood F. Adams, Jr., MD

12:45 – 1:00 PM

Pulmonary Arterial Hypertension: Latest Concepts in Evaluation and Treatment

Lisa J. Rose–Jones, MD

1:00 – 1:15 PM

Atrial Fibrillation: Consequences and Therapeutic Implications in CHF

Anil K. Gehi, MD

1:15 – 1:30 PM

Optimizing Therapy in HF Patients with Sleep Disordered Breathing

William G. Cotts, MD

1:30 – 1:45 PM

Optimizing Care in Heart Failure – Process Matters

Ileana L. Piña, MD, MPH

1:45 – 2:15 PM

The Team Approach to Heart Failure Patient Management

Moderator: Ileana L. Piña, MD, MPH
Panelists: Jana M. Glotzer, MSN, ACNP, Katherine Di Palo, PharmD, Erika Schoenborn, PharmD, and Tammy Long, AGNP

2:15 – 2:30 PM

Break & Virtual Exhibits

Session VI: Clinical Care Workshops

2:30 – 3:00 PM

Nursing Challenges in Caring for the Chronic Heart Failure Patient

Jana M. Glotzer, MSN, ACNP, Sarah Waters, ANP–BC, Carrie Neal, RN, BSN, Tammy Long, AGNP, and Emily Baker, MSN, AGNP–C

3:00 – 3:30 PM

Pharmacotherapeutic Challenges in Treating the Heart Failure Patient

Robert L. Page II, PharmD, Barry E. Bleske, PharmD, and Erika Schoenborn, PharmD

3:30 – 3:50 PM

Optimizing Patient Selection for EP Device and Intervention Therapy

Faisal F. Syed, BSc, MBChB and Matthew Baker, MD

3:50 – 4:20 PM

Advanced and Refractory HF: Individualizing LVAD and Hemodynamic Monitoring Strategies

Robert T. Cole, MD, Elizabeth Volz, MD, Lauren B. Cooper, MD, and Megan Andrews, ANP

4:20 – 4:50 PM

Clinical Update on Cardio–Oncology

Daniel J. Lenihan, MD and Jo Ellen Rodgers, PharmD

4:50 – 5:15 PM

Unusual Cardiomyopathies: Approaches to Evaluation and Management

Mirnela Byku, MD, PhD and Uri Elkayam, MD